Literature DB >> 14675412

A population based, unselected, consecutive cohort of patients with acquired haemophilia A.

Peter Collins1, Nicola Macartney, Richard Davies, Steven Lees, John Giddings, Ray Majer.   

Abstract

Previous studies in acquired haemophilia A have reported on cohorts of patients referred to specialist centres or were retrospective surveys of specialist centre experience. This may have resulted in the literature representing a more severe group of patients than seen in routine haematological practice. We report on a consecutive, unselected cohort of all patients in south and west Wales who presented with acquired haemophilia A between 1996 and 2002. There were 18 patients, an incidence of 1.34/million/year. Compared with previously reported cohorts our patients were older, with a median age of 70 years, and less likely to have an underlying diagnosis (27%). The bleeding phenotype was less severe, with only 27% having life or limb threatening bleeds and 41% required no haemostatic treatment. One patient died of bleeding, but three died of complications related to immunosuppression. Response to immunosuppression was high compared with other series, with 88% of treated patients attaining an undetectable inhibitor and normal factor VIII level. These data suggest that previously reported cohorts may represent more severely affected patients and, whilst guidelines for treatment based on these assumptions may be valid for severely affected patients, they may not be universally applicable.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675412     DOI: 10.1046/j.1365-2141.2003.04731.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  40 in total

1.  Acquired haemophilia heralded by bleeding into the oral mucosa in a patient with bullous pemphigoid, rheumatoid arthritis, and vitiligo.

Authors:  R S Patel; K E Harman; C Nichols; R M Burd; S Pavord
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 2.  Haemophilia imaging: a review.

Authors:  Jody Maclachlan; Antony Gough-Palmer; Rikin Hargunani; Joanna Farrant; Brian Holloway
Journal:  Skeletal Radiol       Date:  2008-09-20       Impact factor: 2.199

Review 3.  The use of desmopressin in acquired haemophilia A: a systematic review.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2011-07-18       Impact factor: 3.443

4.  Acquired haemophilia a in the elderly: case reports.

Authors:  Antonella Tufano; Antonio Coppola; Anna Guida; Ernesto Cimino; Angela Maria De Gregorio; Anna Maria Cerbone; Giovanni Di Minno
Journal:  Curr Gerontol Geriatr Res       Date:  2010-03-03

5.  Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.

Authors:  Massimo Franchini; Giancarlo Castaman; Antonio Coppola; Cristina Santoro; Ezio Zanon; Giovanni Di Minno; Massimo Morfini; Elena Santagostino; Angiola Rocino
Journal:  Blood Transfus       Date:  2015-06-24       Impact factor: 3.443

6.  Consensus recommendations for the diagnosis and treatment of acquired hemophilia A.

Authors:  Peter Collins; Francesco Baudo; Angela Huth-Kühne; Jørgen Ingerslev; Craig M Kessler; Maria E Mingot Castellano; Midori Shima; Jean St-Louis; Hervé Lévesque
Journal:  BMC Res Notes       Date:  2010-06-07

Review 7.  Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

8.  Acquired hemophilia A.

Authors:  Yadav Pandey; Dinesh Atwal; Manojna Konda; Arya Roy; Appalanaidu Sasapu
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-11-20

9.  Characterization of anti-factor VIII antibody in a patient with acquired hemophilia A.

Authors:  Jisu Oh; Yeongmin Lim; Moon Ju Jang; Ji Young Huh; Midori Shima; Doyeun Oh
Journal:  Blood Res       Date:  2013-03-25

Review 10.  Immune response to FVIII in hemophilia A: an overview of risk factors.

Authors:  Kanjaksha Ghosh; Shrimati Shetty
Journal:  Clin Rev Allergy Immunol       Date:  2009-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.